ARCH THERAPEUTICS, INC.

Profile

Company Names

ARCH THERAPEUTICS, INC.

Addresses

1 CHIEFTAIN LANE, NATICK, MA 01760

Phone Numbers

617-395-1397

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2006

State Incorporated:

MASSACHUSETTS

Total Amount Raised:

$445,397.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2013-06-19 
$370,397.00 
$370,397.00 
$0.00 
Debt 
1
2010-09-21 
$75,000.00 
$2,000,000.00 
$1,925,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
 
BISON 
EXECUTIVE OFFICER
ARCH THERAPEUTICS, INC.
AVTAR 
 
DHILLON 
DIRECTOR
PROTOX THERAPEUTICS INC   |  ONCOSEC MEDICAL INC   |  STEVIA FIRST CORP.   |  ARCH THERAPEUTICS, INC.   |  ARCH THERAPEUTICS, INC.   |  EMERALD HEALTH PHARMACEUTICALS INC.   |  NEMUS BIOSCIENCE, INC.
STEVEN 
 
KELLY 
EXECUTIVE OFFICER, DIRECTOR
ARCH THERAPEUTICS, INC.   |  PINTEON THERAPEUTICS, INC.   |  ARTELO BIOSCIENCES, INC.   |  CARMA THERAPEUTICS INC.   |  CARISMA THERAPEUTICS INC.   |  BETTER LIFE PARTNERS INC.   |  BETTER LIFE PARTNERS INC.
TERRENCE 
W. 
NORCHI 
EXECUTIVE OFFICER, DIRECTOR
ARCH THERAPEUTICS, INC.   |  ARCH THERAPEUTICS, INC.
ARTHUR 
 
ROSENTHAL 
DIRECTOR
CAPPELLA INC   |  ARCH THERAPEUTICS, INC.   |  ARCH THERAPEUTICS, INC.
JAMES 
 
SHANNON 
DIRECTOR
INDUS PACIFIC SMALLER COMPANIES FUND LTD   |  INDUS ASIA PACIFIC FUND, LTD.   |  INDUS EUROPE FUND, LTD.   |  INDUS EVENT DRIVEN FUND, LTD.   |  INDUS JAPAN FUND, LTD.   |  INDUS ALTERNATIVE EQUITY FUND, LTD.   |  XANODYNE PHARMACEUTICALS INC   |  INDUS PACIFIC OPPORTUNITIES FUND, LTD.   |  INDUS OMNI FUND, LTD.   |  CERIMON PHARMACEUTICALS, INC.   |  ARCH THERAPEUTICS, INC.   |  INDUS SELECT FUND, LTD.   |  INDUS OREAMNOS FUND, SPC - SEGREGATED PORTFOLIO 1   |  INDUS EMERGING MARKETS FUND, LTD.   |  INDUS CHINA FUND, LTD.   |  INDUS JAPAN LONG ONLY FUND, LTD.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-06-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-06-19 
2010-10-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-09-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#